Target intelligence / Profile preview

novel transcript, sense intronic to GPN2 (ENSG00000289554)

Target
ENSG00000289554
Molecular classification
Other (non-coding RNA, novel transcript, uncharacterized transcript)
01

Overview

ENSG00000289554 is annotated as a "novel transcript, sense intronic to GPN2," meaning it is a transcript with no canonical gene symbol or function, identified on the same DNA strand (sense) and entirely within an intron of the GPN2 gene. Such transcripts are usually discovered through high-throughput RNA sequencing and computational analysis of the transcriptome, and they are not referenced in typical drug target or disease association databases. The function, if any, of this transcript is uncharacterized; it may represent a non-coding RNA or byproduct of transcription rather than a protein-coding gene or regulatory element with medical relevance[1]. As such, there is no evidence for involvement in drug action, disease, or biology beyond its transcriptomic annotation. This entry is likely of interest for transcriptomics benchmarking or annotation, not for drug discovery or therapeutic targeting[1]. Therefore, it should not be considered a therapeutic target or included among well-characterized biological receptors, enzymes, or regulatory proteins.

02

Mechanism of action

None (no drugs target this transcript)

03

Biological functions

Other (no characterized function; potential non-coding RNA role, if any)
04

Disease associations

Other (no established role in disease)

Beyond the preview

Go deeper on novel transcript, sense intronic to GPN2 (ENSG00000289554).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, sense intronic to GPN2 (ENSG00000289554).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call